Home › Funds › Nuveen › Nuveen Global Dividend Growth Fund
Fund family: Nuveen · Filed by NUVEEN INVESTMENT TRUST II (CIK 1041673) · SEC series S000037309
Share classes and tickers: NUGAX (C000115036), NUGCX (C000115037), NUGIX (C000115039)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 726 with, 48 against, 0 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 45 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Nuveen’s manager page (32,446 ballot items across 41 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Nuveen | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.5% | 667 | 94.5% | 28,591 |
| Backed environmental and social shareholder proposals at US companies | n/a | 21 | 16.6% | 779 |
Each ballot item this fund voted is set against the votes of the other Nuveen funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Nuveen funds on all 350 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 438 | 0 |
| Compensation | 82 | 1 |
| Capital Structure | 77 | 0 |
| Corporate Governance | 73 | 19 |
| Audit-related | 44 | 0 |
| Say-on-Pay | 25 | 0 |
| Other Social Issues | 15 | 11 |
| Environment or Climate | 10 | 10 |
| Human Rights or Human Capital/workforce | 6 | 6 |
| Extraordinary Transactions | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $1M | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $1M | 21 | 6 |
| Taiwan Semiconductor Manufacturing Co., Ltd. | June 4, 2026 | $875,005 | 3 | 0 |
| JPMorgan Chase & Co. | May 19, 2026 | $762,348 | 17 | 4 |
| Broadcom Inc. | April 20, 2026 | $679,803 | 10 | 0 |
| AbbVie Inc. | May 8, 2026 | $465,826 | 8 | 1 |
| Mastercard Incorporated | June 16, 2026 | $449,498 | 15 | 2 |
| American Express Company | May 5, 2026 | $448,258 | 17 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 19, 2026 | JPMorgan Chase & Co. | Report on congruence of security, resiliency, and climate initiatives Shareholder proposal | Against | For |
| May 19, 2026 | JPMorgan Chase & Co. | Independent board chairman Shareholder proposal | Against | For |
| May 8, 2026 | AbbVie Inc. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposal | Against | For |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposal | Against | For |
| May 5, 2026 | American Express Company | Shareholder proposal requesting a report on coverage of transgender healthcare treatments for minors. Shareholder proposal | Against | For |
| May 5, 2026 | American Express Company | Shareholder proposal regarding political bias risk oversight. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
774 ballot items at 49 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Nuveen Global Dividend Growth Fund (NUGAX) voted at 49 shareholder meetings of 47 companies, on 774 ballot items in all. Where management made a recommendation, the fund followed it on 93.8% of the items and voted against it 48 times. Its most frequent area of disagreement was corporate governance (19 of its votes against management). It voted on 47 shareholder proposals. It voted FOR the board's own proposals more often than Nuveen's funds as a whole (98.5% against 94.5%). It voted the same way as most Nuveen funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Nuveen’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.